Subjects with Moderate to Severe Endometriosis-Associated PainStatus: open
17-335 - A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethinedrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain
Treatment for Endometriosis
A randomized study evaluating the continued safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult pre-menopausal female subjects. IRB Number 17-335
SponsorsThis trial is sponsored by AbbVie.
Interested in Clinical Trial?
Providers Associated With This Trial
- Botros M. Rizk, M.D., F.R.C.O.G., F.R.C.S., H.C.L.D., F.A.C.O.G., F.A.C.S.Reproductive EndocrinologistDivision Head of Reproductive Endocrinology; Professor of Obstetrics and Gynecology
- Nicolette P. Holliday, M.D.Obstetrician/GynecologistAssistant Professor of Obstetrics and Gynecology